Adaptive RSK‐EphA2‐GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer-Reference-Cited by-同舟云学术

Adaptive RSK‐EphA2‐GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer

Published:2020-03-02 Issue:4 Volume:12 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Moyano‐Galceran Lidia¹^ORCID,Pietilä Elina A²^ORCID,Turunen S Pauliina¹,Corvigno Sara³⁴,Hjerpe Elisabet⁵,Bulanova Daria⁶,Joneborg Ulrika⁷,Alkasalias Twana¹⁸,Miki Yuichiro¹⁹,Yashiro Masakazu⁹,Chernenko Anastasiya²,Jukonen Joonas²,Singh Madhurendra¹,Dahlstrand Hanna³⁴,Carlson Joseph W³,Lehti Kaisa¹²^ORCID

Affiliation:

1. Department of Microbiology, Tumor and Cell Biology Karolinska Institutet Stockholm Sweden

2. Research Programs Unit Individualized Drug Therapy University of Helsinki and Helsinki University Hospital Helsinki Finland

3. Department of Oncology and Pathology Karolinska Institutet Stockholm Sweden

4. Department of Immunology, Genetics and Pathology Uppsala University Uppsala Sweden

5. Department of Obstetrics and Gynecology Visby Hospital Visby Sweden

6. Institute for Molecular Medicine Finland, FIMM University of Helsinki Helsinki Finland

7. Division of Pelvic Cancer Department of Women's and Children's Health Karolinska Institutet and University Hospital Stockholm Sweden

8. Research Centre Salahaddin University‐Erbil Erbil Iraq

9. Department of Gastroenterological Surgery Osaka City University Graduate School of Medicine Osaka Japan

Funder

Karolinska Institutet

Vetenskapsrådet

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201911177

Reference74 articles.

1. New Perspectives on an Old Friend: Optimizing Carboplatin for the Treatment of Solid Tumors

2. Management and Treatment of Recurrent Epithelial Ovarian Cancer

3. Novel Potent and Selective Inhibitors of p90 Ribosomal S6 Kinase Reveal the Heterogeneity of RSK Function in MAPK-Driven Cancers

4. QuPath: Open source software for digital pathology image analysis

5. Protein kinase A can block EphA2 receptor–mediated cell repulsion by increasing EphA2 S897 phosphorylation

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erythropoietin-induced hepatocyte receptor A2 regulates effect of pyroptosis on gastrointestinal colorectal cancer occurrence and metastasis resistance;World Journal of Gastrointestinal Oncology;2024-09-15

2. Cancer plasticity in therapy resistance: Mechanisms and novel strategies;Drug Resistance Updates;2024-09

3. Cell-intrinsic platinum response and associated genetic and gene expression signatures in ovarian cancer cell lines and isogenic models;2024-07-29

4. The EphA2 Receptor Regulates Invasiveness and Drug Sensitivity in Canine and Human Osteosarcoma Cells;Cells;2024-07-16

5. GPRC5A is a potential prognostic biomarker and correlates with immune cell infiltration in non-small cell lung cancer;Translational Lung Cancer Research;2024-05